The majority of UBQLN2 mutations that cause ALS/FTD are located within the PXX domain, which is important for interactions with its protein partners [1], and this is in line with our observation of stronger binding to TBK1 via the C-terminal region of UBQLN2. Here, UBQLN2 is linked to amyotrophic lateral sclerosis.